Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $29,273 | 1,140 | 99.0% |
| Education | $286.61 | 21 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $2,669 | 96 | $0 (2023) |
| Amgen Inc. | $2,602 | 81 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $2,202 | 54 | $0 (2023) |
| PFIZER INC. | $1,792 | 83 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $1,763 | 42 | $0 (2021) |
| AbbVie Inc. | $1,703 | 72 | $0 (2023) |
| Novo Nordisk Inc | $1,636 | 69 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,370 | 74 | $0 (2023) |
| Esperion Therapeutics, Inc. | $1,070 | 38 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,016 | 47 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $2,878 | 103 | AbbVie Inc. ($722.18) |
| 2022 | $5,126 | 199 | AstraZeneca Pharmaceuticals LP ($489.99) |
| 2021 | $5,665 | 240 | Biohaven Pharmaceuticals, Inc. ($657.48) |
| 2020 | $2,696 | 146 | AstraZeneca Pharmaceuticals LP ($354.14) |
| 2019 | $4,280 | 135 | Amgen Inc. ($722.37) |
| 2018 | $4,391 | 169 | Janssen Pharmaceuticals, Inc ($562.73) |
| 2017 | $4,524 | 169 | Janssen Pharmaceuticals, Inc ($649.03) |
All Payment Transactions
1,161 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/01/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Inflammation | ||||||
| 11/15/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Diabetes | ||||||
| 11/14/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: Diabetes | ||||||
| 11/03/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: Endocrinology | ||||||
| 11/02/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: INSOMNIA | ||||||
| 10/30/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $2.40 | General |
| Category: Inflammation | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/19/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Diabetes | ||||||
| 10/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: PAIN | ||||||
| 09/27/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
| 09/13/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Inflammation | ||||||
| 09/11/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Cardio-renal | ||||||
| 08/30/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $3.44 | General |
| Category: Cardio-renal | ||||||
| 08/23/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $3.62 | General |
| Category: Inflammation | ||||||
| 08/22/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/22/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Oncology | ||||||
| 08/18/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: RESPIRATORY | ||||||
| 08/18/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Diabetes | ||||||
| 08/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Diabetes | ||||||
| 08/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 303 | 522 | $51,454 | $22,233 |
| 2022 | 10 | 427 | 701 | $70,631 | $32,485 |
| 2021 | 10 | 440 | 743 | $68,153 | $32,744 |
| 2020 | 13 | 706 | 1,266 | $106,472 | $51,406 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 248 | $31,000 | $12,786 | 41.2% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 26 | 27 | $5,454 | $2,446 | 44.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 32 | 48 | $5,145 | $2,419 | 47.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 20 | 20 | $3,580 | $2,402 | 67.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 14 | $2,478 | $922.02 | 37.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 54 | 69 | $737.00 | $579.60 | 78.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 33 | 56 | $2,520 | $533.12 | 21.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 16 | 20 | $300.00 | $101.60 | 33.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 20 | $240.00 | $44.00 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 108 | 301 | $38,694 | $15,338 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 63 | 63 | $12,038 | $7,842 | 65.1% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 37 | 43 | $6,020 | $2,780 | 46.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 39 | 39 | $3,822 | $2,673 | 69.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 32 | 46 | $4,888 | $2,264 | 46.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 35 | 79 | $3,555 | $757.59 | 21.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 20 | $488.00 | $478.24 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 66 | 75 | $651.00 | $222.00 | 34.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 14 | 18 | $270.00 | $91.99 | 34.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 13 | 17 | $205.00 | $37.69 | 18.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 123 | 343 | $40,854 | $18,354 | 44.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 77 | 77 | $17,445 | $9,762 | 56.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 41 | 41 | $3,075 | $2,676 | 87.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 37 | 72 | $3,198 | $689.41 | 21.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 37 | $1,014 | $378.35 | 37.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 20 | 20 | $420.00 | $316.60 | 75.4% |
About Dr. Alan Bierlein, MD
Dr. Alan Bierlein, MD is a Family Medicine healthcare provider based in Bristol, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063493997.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Bierlein, MD has received a total of $29,560 in payments from pharmaceutical and medical device companies, with $2,878 received in 2023. These payments were reported across 1,161 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($29,273).
As a Medicare-enrolled provider, Bierlein has provided services to 1,876 Medicare beneficiaries, totaling 3,232 services with total Medicare billing of $138,869. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Bristol, IN
- Active Since 11/08/2005
- Last Updated 04/15/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063493997
Products in Payments
- VRAYLAR (Drug) $1,643
- FARXIGA (Drug) $1,458
- TRULICITY (Drug) $1,352
- XARELTO (Drug) $1,160
- NURTEC ODT (Drug) $1,012
- JARDIANCE (Drug) $882.34
- TRELEGY ELLIPTA (Drug) $849.64
- NEXLIZET (Drug) $747.21
- ELIQUIS (Drug) $708.77
- Ozempic (Drug) $694.96
- Kerendia (Drug) $691.61
- Repatha (Biological) $673.62
- INVOKANA (Drug) $602.65
- Aimovig (Biological) $564.75
- BELSOMRA (Drug) $479.16
- EVENITY (Biological) $458.88
- Prolia (Biological) $443.19
- Vascepa (Drug) $443.03
- AUSTEDO (Drug) $428.22
- CHANTIX (Drug) $407.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bristol
Andrew Brockmyre, Md, MD
Family Medicine — Payments: $31,782
Justin Grannell, Do, DO
Family Medicine — Payments: $23,452
Kenneth Hess, Do, DO
Family Medicine — Payments: $12,740
Dr. William Astin, Md, MD
Family Medicine — Payments: $12,017
Dr. Christopher Belletieri, Do, DO
Family Medicine — Payments: $11,996
Lisa Felsman, Md, MD
Family Medicine — Payments: $8,338